Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of butylphthalide sodium chloride injection for acute ischemic stroke
ChiCTR2100046094Phase 4Recruiting
- Sponsor
- Tianjin Nankai Hospital
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of butylphthalide in ischemic stroke (2 arms), sponsored by Tianjin Nankai Hospital. Primary endpoints: NIHSS score, Barthel Index score and 1 more. Started Mar 2021; status: recruiting.
02
Drugs
butylphthalide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2100046094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046094.